Sanofi and GSK start new study of COVID-19 vaccine
Sanofi and GlaxoSmithKline (GSK) have announced the initiation of a new Phase II study with 720 volunteers aged 18 and over to select the...
One dose of Pfizer/BioNTech vaccine provides high levels of protection
First real-world UK data analysed by Public Health England (PHE) has shown that the Pfizer/BioNTech vaccine provides high levels of protection against infection and...
GSK and Vir Biotechnology expand coronavirus collaboration
GlaxoSmithKline plc (GSK) and Vir Biotechnology, Inc. have entered into an agreement to expand their existing collaboration to include the research and development of...
Why therapeutics are key to winning the COVID-19 battle
As the number of SARS-CoV-2 infections and deaths continues to grow, the focus of the world rests on the promise of a mass-vaccination program....
Blueprint launched for NHS reform following COVID-19 pandemic
The Health and Social Care Secretary, with the support of NHS England and health and care system leaders, will today set out new proposals...
World’s first clinical trials of COVID-19 vaccine combination
In a bid to combat future mutations of COVID-19, a joint research programme will begin in February 2021 to assess the immunogenicity and safety...
Oxford/AstraZeneca COVID-19 vaccine offers limited protection against South African variant
Analysis submitted as a pre-print prior to peer-review publication has shown that a two-dose regimen of the Oxford/AstraZeneca COVID-19 vaccine provides minimal protection against...
One dose of Oxford/AstraZeneca COVID-19 vaccine could provide sustained protection
Researchers at the University of Oxford have published in Preprints with The Lancet an analysis of further data from the ongoing trials of the Oxford coronavirus...
Sputnik V COVID-19 vaccine demonstrates 91.6% efficacy
The Lancet has published interim results of a Phase III clinical trial of Sputnik V, confirming the vaccine demonstrated efficacy of 91.6%. Sputnik V,...
EU authorisation for AstraZeneca’s COVID-19 vaccine
AstraZeneca’s COVID-19 vaccine has been recommended for conditional marketing authorisation (CMA) in the European Union (EU) for active immunisation to prevent COVID-19 in individuals...
Latest articles
Government launches call for evidence to improve women’s health and care
The government is launching a 12-week call for evidence to better understand women’s experiences of the health and care system. Launching to coincide with International...
COVID-19 and key changes one year on
One year on from the first confirmed case of COVID-19 in the UK, Oli Hudson, Content Director at Wilmington Healthcare, takes a look at...
FDA approves Roche’s Actemra/RoActemra for interstitial lung disease
Roche has announced that the U.S. Food and Drug Administration (FDA) has approved Actemra®/RoActemra® (tocilizumab) subcutaneous injection for slowing the rate of decline in...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
Pharma marketing: UK vs US
Marketing medicines is a totally different ball game on each side of the pond.
The US is the only country, apart from New Zealand, which...
The role of women in the NHS in England
This International Women’s Day, NHS Digital has published an analysis of the role of women in the NHS in England. Women account for more than...
Nasal spray to protect against COVID-19 is ready for use in humans
A nasal spray to provide protection against the COVID-19 virus has been formulated by researchers at the University of Birmingham, UK, using compounds already...